(Q34647153)

English

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

scientific article

Statements

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial (English)
José Valdez Madruga
Daniel Berger
Marilyn McMurchie
Fredy Suter
Denes Banhegyi
Dorece Norris
Eric Lefebvre
Marie-Pierre de Béthune
Frank Tomaka
Martine De Pauw
Tony Vangeneugden
Sabrina Spinosa-Guzman
TITAN study group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit